ArticleCureus2024
Efficacy of Immediate Continuous Oxytocin Administration After Twin Cesarean Delivery.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anesthetic approaches for malpresentation and multiple gestation.Current opinion in anaesthesiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to investigate the efficacy of continuous oxytocin administration after completion of routine oxytocin administration during the third stage of labor in patients with twin pregnancies delivered via cesarean delivery (CD).
methodsThis retrospective case-control study was conducted between April 2014 and March 2024, and it included 156 women with twin pregnancies. The oxytocin group included patients who were administered continuous oxytocin 2 IU/h until 24 hours after delivery after completion of oxytocin 5 IU intravenous injection immediately after delivery as the routine procedure. The control group included patients who underwent the routine oxytocin procedure only. We conducted overlap propensity score-weighted analyses and inverse probability-weighted analyses in parallel to compare the incidence of postpartum hemorrhage (PPH) and adverse events within 24 hours after CD, including the mean amount of lochia, the incidence of blood transfusion, shock, and additional procedures to control bleeding, and reduction in hemoglobin (Hb) levels and hematocrit (Ht) values before and after CD.
resultsIn the overlap propensity score-weighted analysis, the mean amount of lochia within 24 hours after CD, reduction in Hb levels, and reduction in Ht values were significantly lower in the oxytocin versus the control group (177 g and 383 g, respectively; (95% confidence interval (CI), -328.5 to -84.5);
conclusionContinuous oxytocin administration after completion of oxytocin administration during the third stage of labor may reduce the incidence of PPH after CD for twin pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.